Remove Books Remove Immunization Remove Vaccines
article thumbnail

How To Start A Vaccine Program In Your Pharmacy

DiversifyRx

Are you finally thinking of starting a vaccine program in your independent pharmacy? Adding vaccine administration to your list of pharmacy services is a great way to serve and protect your community while increasing your pharmacy’s visibility, revenue, and profit. Additional revenue Vaccinations can be a profitable service.

article thumbnail

Alnylam sues Pfizer, Moderna over COVID-19 vaccines

pharmaphorum

Alnylam claims it is owed a slice of the massive revenues booked by Pfizer and Moderna for their mRNA-based COVID-19 vaccines, because they are both infringing patents its holds on a delivery technology. Moderna meanwhile booked around $18 billion from SpikeVax in 2021 and is forecasting around the same again this year.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pfizer ups pressure on Merck with Prevnar, flu vaccine co-dosing study

pharmaphorum

Pfizer’s new Prevnar 20 conjugate pneumococcal vaccine can be dosed at the same time as the seasonal flu jab, without any impact on either shot’s effectiveness, according to a new study. “However, vaccination rates decline when someone needs to make multiple appointments to receive these vaccines,” he added.

article thumbnail

STAT+: Pharmalittle: We’re reading about a Covid-flu shot setback, mpox vaccine supplies, and more

STAT

You could hit the proverbial pause button to curl up with a good book or stream a few moving pictures. The combination vaccine met its goal in generating an immune response against influenza A and against the SARS-CoV-2 virus, which causes Covid. The vaccine developer has about 300,000 doses ready for shipping immediately.

Vaccines 111
article thumbnail

Moderna banks $1.1bn in COVID-19 vaccine deposits, signs Japan supply deal

pharmaphorum

Moderna is still preparing for the launch of its COVID-19 vaccine mRNA-1273 – assuming phase 3 trials go to plan – but has already received $1.1 That is the basis for filing for emergency use authorisation (EUA) of the vaccine in the US, according to criteria set out by the FDA. billion in deposits for the shot.

Vaccines 100
article thumbnail

Resourceful or risky? The UK’s controversial COVID-19 vaccine strategy

pharmaphorum

As COVID-19 vaccines are hastily deployed in the UK for priority groups, a debate rages over the government’s controversial strategy to delay time between vaccine doses. When the UK announced the approval of the Pfizer-BioNTech and Oxford/AstraZeneca COVID-19 vaccines, it marked an exciting moment for the nation.

article thumbnail

Resourceful or risky? The UK’s controversial COVID-19 vaccine strategy

pharmaphorum

As COVID-19 vaccines are hastily deployed in the UK for priority groups, a debate rages over the government’s controversial strategy to delay time between vaccine doses. When the UK announced the approval of the Pfizer-BioNTech and Oxford-AstraZeneca COVID-19 vaccines, it marked an exciting moment for the nation.